Pekin Hardy Strauss’s CME Group CME Stock Holding History

Pekin Hardy Strauss’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.02M	Sell	10,235 -139	-1%	-$41.3K	0.32%	82
2025 Q4	$2.83M	Sell	10,374 -138	-1%	-$37.5K	0.26%	99
2025 Q3	$2.84M	Buy	10,512 +9	+0.1%	+$2.45K	0.28%	93
2025 Q2	$2.89M	Buy	10,503 +83	+0.8%	+$22.6K	0.33%	76
2025 Q1	$2.76M	Sell	10,420 -162	-2%	-$40K	0.33%	79
2024 Q4	$2.46M	Sell	10,582 -384	-4%	-$88.3K	0.31%	84
2024 Q3	$2.42M	Sell	10,966 -1,355	-11%	-$280K	0.31%	85
2024 Q2	$2.42M	Sell	12,321 -641	-5%	-$132K	0.33%	81
2024 Q1	$2.79M	Sell	12,962 -128	-1%	-$26.9K	0.38%	74
2023 Q4	$2.76M	Sell	13,090 -31	-0.2%	-$6.61K	0.39%	70
2023 Q3	$2.63M	Sell	13,121 -579	-4%	-$115K	0.41%	69
2023 Q2	$2.54M	Buy	13,700 +82	+0.6%	+$15.2K	0.28%	70
2023 Q1	$2.61M	Buy	13,618 +1,084	+9%	+$196K	0.35%	70
2022 Q4	$2.11M	Buy	12,534 +227	+2%	+$39.4K	0.29%	77
2022 Q3	$2.18M	Buy	12,307 +814	+7%	+$161K	0.35%	76
2022 Q2	$2.35M	Buy	11,493 +1,717	+18%	+$364K	0.33%	78
2022 Q1	$2.33M	Sell	9,776 -573	-6%	-$135K	0.29%	83
2021 Q4	$2.36M	Sell	10,349 -13	-0.1%	-$2.86K	0.32%	87
2021 Q3	$2M	Sell	10,362 -5	-0%	-$1.01K	0.29%	96
2021 Q2	$2.21M	Sell	10,367 -761	-7%	-$161K	0.31%	88
2021 Q1	$2.27M	Buy	11,128 +171	+2%	+$33.7K	0.36%	76
2020 Q4	$2M	Sell	10,957 -3	-0%	-$510	0.35%	73
2020 Q3	$1.83M	Sell	10,960 -69	-0.6%	-$11.6K	0.38%	67
2020 Q2	$1.79M	Sell	11,029 -154	-1%	-$27.6K	0.4%	61
2020 Q1	$1.93M	Sell	11,183 -820	-7%	-$163K	0.43%	54
2019 Q4	$2.41M	Buy	12,003 +39	+0.3%	+$8K	0.4%	63
2019 Q3	$2.53M	Sell	11,964 -463	-4%	-$96.7K	0.49%	52
2019 Q2	$2.41M	Sell	12,427 -558	-4%	-$103K	0.48%	51
2019 Q1	$2.14M	Sell	12,985 -332	-2%	-$58.7K	0.17%	56
2018 Q4	$2.5M	Buy	13,317 +46	+0.3%	+$8.49K	0.44%	52
2018 Q3	$2.26M	Buy	13,271 +47	+0.4%	+$7.91K	0.39%	61
2018 Q2	$2.17M	Sell	13,224 -317	-2%	-$51.8K	0.41%	57
2018 Q1	$2.19M	Sell	13,541 -265	-2%	-$42.2K	0.4%	60
2017 Q4	$2.02M	Buy	13,806 +54	+0.4%	+$7.69K	0.37%	60
2017 Q3	$1.87M	Buy	13,752 +60	+0.4%	+$7.58K	0.35%	66
2017 Q2	$1.72M	Buy	13,692 +64	+0.5%	+$7.65K	0.27%	64
2017 Q1	$1.62M	Buy	13,628 +395	+3%	+$47.5K	0.32%	61
2016 Q4	$1.53M	Sell	13,233 -642	-5%	-$71.4K	0.14%	63
2016 Q3	$1.45M	Buy	13,875 +64	+0.5%	+$6.68K	0.25%	63
2016 Q2	$1.34M	Buy	13,811 +39	+0.3%	+$3.69K	0.3%	63
2016 Q1	$1.32M	Buy	13,772 +443	+3%	+$40.3K	0.31%	67
2015 Q4	$1.21M	Buy	13,329 +60	+0.5%	+$5.65K	0.27%	68
2015 Q3	$1.23M	Buy	13,269 +61	+0.5%	+$5.8K	0.28%	64
2015 Q2	$1.23M	Sell	13,208 -857	-6%	-$80K	0.24%	68
2015 Q1	$1.33M	Sell	14,065 -356	-2%	-$33K	0.25%	60
2014 Q4	$1.28M	Sell	14,421 -2,695	-16%	-$228K	0.19%	103
2014 Q3	$1.37M	Buy	17,116 +71	+0.4%	+$5.35K	0.23%	55
2014 Q2	$1.21M	Sell	17,045 -3,500	-17%	-$246K	0.19%	55
2014 Q1	$1.52M	Buy	20,545 +1,675	+9%	+$126K	0.25%	49
2013 Q4	$1.48M	Sell	18,870 -175	-0.9%	-$13.7K	0.23%	51
2013 Q3	$1.41M	Sell	19,045 -4,620	-20%	-$340K	0.22%	50
2013 Q2	$1.8M	Buy	+23,665	New	+$1.55M	0.31%	42

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pekin Hardy Strauss's CME Position: Q1 2026 in Review

Pekin Hardy Strauss reduced its CME Group (CME) stake by 1.3% in Q1 2026, selling an estimated $41.3K and leaving 10,235 shares worth $3.02M. The position accounts for 0.32% of the portfolio, ranked #82.

Pekin Hardy Strauss first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Pekin Hardy Strauss held 10,235 shares of CME Group worth $3.02M as of Q1 2026.
Pekin Hardy Strauss sold 139 CME Group shares in Q1 2026, an estimated $41.3K.
CME Group made up 0.32% of Pekin Hardy Strauss's portfolio in Q1 2026, its #82 holding.
Pekin Hardy Strauss first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.